Frontlight ResearchEarly access
Trial site
Istanbul University Istanbul Medical Faculty
- 9running trials
- 4closed trials
The trials here
What the 13 trials at this site are about, from their registry records.
- Conditions
- Antiphospholipid syndrome2 trials
- Dermatomyositis and polymyositis (myositis)2 trials
- Immune thrombocytopenia (ITP)2 trials
- Multiple myeloma2 trials
- Amyloidosis1 trial
- Endometrial cancer1 trial
- Follicular lymphoma1 trial
- Frontotemporal dementia1 trial
- Multiple sclerosis1 trial
- Ovarian cancer1 trial
- Prostate cancer1 trial
- Psoriasis1 trial
- and 2 more
- Phase
- Phase 37 trials
- Phase 12 trials
- Phase 2/32 trials
- Phase 1/21 trial
- Phase 21 trial
- Status
- Active, not recruiting5 trials
- Completed3 trials
- Recruiting3 trials
- Enrolling by invitation1 trial
- Withdrawn1 trial
- Lead sponsor
- Janssen Research & Development, LLC6 trials
- Chugai Pharmaceutical2 trials
- BioNTech SE1 trial
- Daiichi Sankyo1 trial
- Denali Therapeutics Inc.1 trial
- and 2 more
Running trials
Recruiting
Recruiting
Enrolling by invitation
Phase 1b Long-term Extension Trial of RAY121 in Immunological Diseases (RAINBOW-LTE Trial)
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
A Study of Guselkumab in Participants With Moderately to Severely Active Ulcerative Colitis
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Antiphospholipid syndrome1 recruiting
- Dermatomyositis and polymyositis (myositis)1 recruiting
- Endometrial cancer1 recruiting
- Follicular lymphoma1 recruiting
- Immune thrombocytopenia (ITP)1 recruiting
- Multiple sclerosis1 recruiting
Closed trials
Recruiting
Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)
Completed
Completed
Completed
Site data: ClinicalTrials.govUpdated 18 Nov 2026